Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,430.00
Bid: 3,430.00
Ask: 3,450.00
Change: 40.00 (1.18%)
Spread: 20.00 (0.583%)
Open: 3,415.00
High: 3,430.00
Low: 3,415.00
Prev. Close: 3,390.00
CLDN Live PriceLast checked at -
Caledonia is an Investment Trust

To grow net assets and dividends over the long term, whilst managing risk to avoid permanent loss of capital.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

15 Nov 2018 07:00

RNS Number : 4064H
Caledonia Investments PLC
15 November 2018
 

 

 

 

APPOINTMENT OF CHIEF FINANCIAL OFFICER

 

The board of Caledonia Investments plc ("Caledonia" or the "Company") is pleased to announce that it has appointed Tim Livett as Caledonia's Chief Financial Officer with effect from 12 March 2019.

 

Tim will join Caledonia from the Wellcome Trust, where he has been Chief Financial Officer since 2014. Prior to this position, he worked for Virgin Atlantic for ten years, initially as Finance Director and latterly as Chief Financial Officer, having previously held senior financial positions at Hudson Global Resources and British Airways.

 

As previously announced, Stephen King, Caledonia's current Finance Director, will step down from the board and leave the Company on 30 November 2018, following the Company's half-year results. Caledonia's Finance team will report directly to the Chief Executive pending Tim Livett's arrival.

 

Commenting on the appointment, Will Wyatt, Caledonia's Chief Executive, said:

 

"We are delighted that Tim Livett will be joining our board. His knowledge and insight gained from his responsibilities at Wellcome, in particular from his risk and performance oversight of its asset management division, which manages the Trust's £23bn mixed asset portfolio, will be highly complementary to our management team."

 

"I would also like again to extend the board's thanks to Stephen King for his contribution to Caledonia over his past nine years as Finance Director and we wish him every success in the future."

 

Tim Livett said:

 

"I am thrilled to be joining Caledonia, a company with a unique approach and proven track record of identifying excellent investment opportunities to build long-term value. Caledonia has a long heritage and a bright future and I look forward to working with Will and the team."

 

15 November 2018

 

For further information please contact:

 

 

Caledonia Investments plc

+44 20 7802 8080

Will Wyatt,

Chief Executive

 

 

 

 

 

Tulchan Communications

+44 20 7353 4200

Tom Murray

Lisa Jarrett-Kerr

 

 

 

 

 

Notes:

 

1. There are no disclosures to be made pursuant to LR 9.6.13 in relation to Mr Livett.

2. Mr Livett's remuneration package will be in accordance with Caledonia's approved remuneration policy and will include the following:

 

· A basic salary of £375,000;

· A bonus opportunity of up to 100% of basic salary, of which any bonus in excess of 50% of basic salary will be compulsorily deferred into Caledonia shares for three years under the Company's deferred bonus plan;

· An annual award of 150% of basic salary under the Company's performance share scheme, which will vest based on performance as to one-third over three years and two-thirds over five years;

· A pension entitlement (cash allowance or contribution) of 17.5% of basic salary;

· Other customary benefits, such as private medical cover and death-in-service insurance.

 

No special sign-on commitments or compensation payments for loss of benefits from his previous employer will be made in relation to Mr Livett's appointment.

 

3. Mr Livett and persons closely associated with him do not hold any shares in Caledonia.

 

4. Information required by section 430 (2B) of the Companies Act 2006 relating to Mr King's cessation as a director of the Company is available on Caledonia's website.

 

 

END

 

Notes for editors:

 

Caledonia Investments plc

Caledonia is a self-managed investment trust company listed on the London Stock Exchange with net assets of £2.0bn as at 31 October 2018. The Company maintains a concentrated portfolio of international quoted, unquoted and fund investments and has paid an increasing annual dividend for 51 years.

 

For additional information on Caledonia, please visit www.caledonia.com.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABZLLFVFFBFBL
Date   Source Headline
9th Mar 20159:14 amRNSNet Asset Value(s)
9th Mar 20157:00 amRNSHolding(s) in Company
3rd Mar 201510:39 amRNSHolding(s) in Company
27th Feb 20155:28 pmRNSHolding(s) in Company
19th Feb 20152:17 pmRNSHolding(s) in Company
5th Feb 20152:31 pmRNSNet Asset Value(s)
26th Jan 201510:52 amRNSHolding(s) in Company
16th Jan 20154:30 pmRNSHolding(s) in Company
12th Jan 201510:45 amRNSHolding(s) in Company
8th Jan 201510:35 amRNSInterim Management Statement
8th Jan 201510:31 amRNSNet Asset Value(s)
2nd Jan 20157:00 amRNSBlocklisting Interim Review
18th Dec 20149:45 amRNSDirector/PDMR Shareholding
5th Dec 201410:44 amRNSNet Asset Value(s)
1st Dec 20144:40 pmRNSHolding(s) in Company
28th Nov 20149:19 amRNSDirector/PDMR Shareholding
25th Nov 201412:37 pmRNSHolding(s) in Company
25th Nov 20147:00 amRNSHalf Yearly Report
10th Nov 20149:22 amRNSNet Asset Value(s)
7th Oct 20143:20 pmRNSNet Asset Value(s)
30th Sep 20144:47 pmRNSTransaction in Own Shares
30th Sep 20144:42 pmRNSTotal Voting Rights
25th Sep 20145:10 pmRNSHolding(s) in Company
15th Sep 20145:08 pmRNSTransaction in Own Shares
5th Sep 20148:15 amRNSNet Asset Value(s)
1st Sep 20148:43 amRNSHolding(s) in Company
22nd Aug 20143:24 pmRNSHolding(s) in Company
18th Aug 20143:14 pmRNSDirector/PDMR Shareholding
6th Aug 20141:43 pmRNSNet Asset Value(s)
21st Jul 201411:03 amRNSDirector/PDMR Shareholding
17th Jul 20141:06 pmRNSResult of AGM
7th Jul 201411:25 amRNSInterim Management Statement
7th Jul 201411:19 amRNSNet Asset Value(s)
2nd Jul 20141:21 pmRNSHolding(s) in Company
1st Jul 20149:18 amRNSBlocklisting Interim Review
27th Jun 20148:35 amRNSCapital Markets Day
19th Jun 20149:32 amRNSUpdate to Net Asset Value
17th Jun 20141:07 pmRNSAnnual Financial Report
13th Jun 20141:31 pmRNSDirector/PDMR Shareholding
6th Jun 20144:24 pmRNSDirector/PDMR Shareholding
6th Jun 20143:08 pmRNSNet Asset Value(s)
30th May 20149:03 amRNSDirector Declaration
28th May 20144:00 pmRNSDirector/PDMR Shareholding
28th May 20147:00 amRNSFinal Results
22nd May 201412:27 pmRNSHolding(s) in Company
9th May 20144:23 pmRNSHolding(s) in Company
9th May 201410:29 amRNSNet Asset Value(s)
7th Apr 20143:25 pmRNSNet Asset Value(s)
7th Mar 20149:56 amRNSNet Asset Value(s)
6th Feb 20149:52 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.